# Define the model parameters and equations
# Using mrgsolve - differential equations
# This compiled model is used for simulating n individuals and their concentration-time profiles
code <- '
$CMT			// Initial conditions for compartments
					CENT,	// Central compartment for PK
					PERI,	// Peripheral compartment for PK
					STEM,	// Stem compartment for PD
					ANC,	// Absolute neutrophil count for PD
					TRANSIT1,	// Transit compartment 1 for PD
					TRANSIT2,	// Transit compartment 2 for PD
					TRANSIT3, // Transit compartment 3 for PD
					INPUT, // Input compartment for PD
					G4N1	// Time spent in Grade 4 Neutropenia

$PARAM		// Population pharmacokinetic parameters
					POPCL = 28.9,	// Clearance, L/h (THETA1)
					POPV1 = 19.5,	// Volume of central compartment, L (THETA2)
					POPQ = 28.5,	// Inter-compartmental clearance, L/h (THETA3)
					POPV2 = 20.9,	// Volume of peripheral compartment, L (THETA4)
					SHARE_ETA = 1.31,	// ETA shared between CL and V2 (THETA5)
					W = 0.693,	// Standard deviation of residuals for PK (THETA9)

					// Population pharmacodynamic parameters
					POPBASE = 5.66, // (THETA10)
					POPSLOPE = 7.41,	// (THETA11)
					POPMTT = 96,	// Mean transit time, days (THETA12)
					POPTHALF = 7,	// (THETA15)
					POPIP01 = 109,	// (THETA16)
					POPIP02 = 0.0564,	// (THETA17)
					POPIPT = 14.7,	// (THETA18)

					// Covariate effects
					CRCL_CL = 0.193,	// Effect of CrCL on CL (THETA6)
					SLC7A5_V2 = -0.130,	// Effect of SLC7A5 on V2 (THETA7)
					HCT_CL = 0.216,	// Effect of HCT on CL (THETA8)
					ENDO_POWER1 = 0.188,	// Endogenous GSCF effect (THETA13)
					NEUP_POWER1 = 0.0313,	// Neupogen GSCF effect (THETA14)
					GCSF_MTT = 0.157,	// Effect of GCSF on MTT (THETA19)
					ANCBASE_BASE = 0.226,	// Effect of ANC on BASE (THETA20)
					GCSF_SLOPE = 0.421,	// Effect of GSCF on SLOPE (THETA21)
					RACE_MTT = -0.0894,	// Effect of RACE on MTT (THETA22)
					CRCL_MTT = -0.056,	// Effect of CrCL on MTT (THETA23)
					SEX_SLOPE = 0.214,	// Effect of SEX on SLOPE (THETA24)
					HCT_SLOPE = 0.646,	// Effect of HCT on SLOPE (THETA25)
					HCT_BASE = 0.582,	// Effect of HCT on BASE (THETA26)

					// Default covariate values for simulation
					CRCL = 91.94,	// Creatinine clearance (mL/min)
					HCT = 32.5,	// Haematocrit (%)
					SEX = 0,	// Male (1) or female (0)
					FFM = 59.9,	// Fat free mass (kg)
					SLC7A5 = 0,	// AA or AG (0) versus GG (1)
					GCSF = 0,	// Neupogen administered on Day 1 (0) or Day 7 (1)
					RACE = 0,	// Caucasian or unknown (0) versus African-American (1)
					ANCBASE = 3.5	// Baseline ANC (K/ÂµL)

$OMEGA		name = "BSV"
					block = FALSE
					labels = s(BSVCL,BSVV1,BSVQ,BSVBASE,BSVSLOPE,BSVMTT,BSVIP0)
					0.0792	// BSVCL
					0.0740	// BSVV1
					0.297	// BSVQ
					0.1	// BSVBASE
					0.0631	// BSVSLOPE
					0.00561	// BSVMTT
					0.23	// BSVIP0

$SIGMA		block = FALSE
					labels = s(ERRPK,ERRPD)
					0.0584	// Log-normal proportional error for PK observations
					1	// Additive error for PD observations

$MAIN			//////////////////////
					// PHARMACOKINETICS //
					//////////////////////

					// Infusion duration
					D_CENT = 0.5;	// 30 minutes

					// Covariate effects
					double SLC7A5COV_V2 = 1;
					if (SLC7A5 == 1) SLC7A5COV_V2 = 1 + SLC7A5_V2;

					// Individual parameter values
					if (ID == 1) {
						BSVCL = 0;
						BSVV1 = 0;
						BSVQ = 0;
					}
					double CL = POPCL*pow(FFM/59.9,0.75)*pow(CRCL/91.94,CRCL_CL)*pow(HCT/32.5,HCT_CL)*exp(BSVCL);
					double V1 = POPV1*(FFM/59.9)*exp(BSVV1);
					double Q = POPQ*pow(FFM/59.9,0.75)*exp(BSVQ);
					double V2 = POPV2*(FFM/59.9)*SLC7A5COV_V2*exp(BSVCL*SHARE_ETA);

					// Individual micro-rate constants
					double K10 = CL/V1;
					double K12 = Q/V1;
					double K21 = Q/V2;

					// Initial conditions
					CENT_0 = 0;
					PERI_0 = 0;

					//////////////////////
					// PHARMACODYNAMICS //
					//////////////////////

					// Covariate effects
					double GCSFCOV_SLOPE = 1;
					if (GCSF == 1) GCSFCOV_SLOPE = 1 + GCSF_SLOPE;
					double GCSFCOV_MTT = 1;
					if (GCSF == 1) GCSFCOV_MTT = 1 + GCSF_MTT;
					double SEXCOV_SLOPE = 1;
					if (SEX == 1) SEXCOV_SLOPE = 1 + SEX_SLOPE;
					double RACECOV_MTT = 1;
					if (RACE == 1) RACECOV_MTT = 1 + RACE_MTT;
					double ON_IP0 = 1;
					if (GCSF == 1) ON_IP0 = 0;

					// Population parameter values
					if (ID == 1) {
						BSVBASE = 0;
						BSVSLOPE = 0;
						BSVMTT = 0;
						BSVIP0 = 0;
					}
					double BASE = POPBASE*pow(ANCBASE/3.5,ANCBASE_BASE)*pow(HCT/32.5,HCT_BASE)*exp(BSVBASE);
					double SLOPE = POPSLOPE*GCSFCOV_SLOPE*SEXCOV_SLOPE*pow(HCT/32.5,HCT_SLOPE)*exp(BSVSLOPE);
					double MTT = POPMTT*GCSFCOV_MTT*RACECOV_MTT*pow(CRCL/91.94,CRCL_MTT)*exp(BSVMTT);
					double KE = log(2)/POPTHALF;
					double IP0 = ON_IP0*POPIP01+(1-ON_IP0)*POPIP02*exp(BSVIP0);
					double IPT = POPIPT;

					// Individual rate constants
					double K = 4/MTT;

					// Initial conditions
					STEM_0 = KE*BASE/K;
					ANC_0 = BASE;
					TRANSIT1_0 = KE*BASE/K;
					TRANSIT2_0 = KE*BASE/K;
					TRANSIT3_0 = KE*BASE/K;
					INPUT_0 = IP0;
					G4N1_0 = 0;

$ODE			//////////////////////
					// PHARMACOKINETICS //
					//////////////////////

					// Differential equations
					dxdt_CENT = K21*PERI -K10*CENT -K12*CENT;
					dxdt_PERI = K12*CENT -K21*PERI;

					//////////////////////
					// PHARMACODYNAMICS //
					//////////////////////

					// Other variables required for differential equations
					double QN = 0;
					if (GCSF == 0 & SOLVERTIME > 72) QN = 1;
					if (GCSF == 1 & SOLVERTIME > 216) QN = 1;
					double POWER1 = ENDO_POWER1 + QN*NEUP_POWER1;
					double FN = pow(BASE/0.001,POWER1);
					if (ANC > 0.001) FN = pow(BASE/ANC,POWER1);

					double KIN = 0;
					if (GCSF == 0 & SOLVERTIME > 72) KIN = 1/IPT;
					if (GCSF == 1 & SOLVERTIME > 216) KIN = 1/IPT;

					double CP = CENT/V1;
					double DRUG = SLOPE*CP;

					// Differential equations
					dxdt_STEM = K*STEM*(1-DRUG)*FN -K*STEM;
					dxdt_ANC = K*TRANSIT3 -KE*ANC +KIN*INPUT;
					dxdt_TRANSIT1 = K*STEM -K*TRANSIT1;
					dxdt_TRANSIT2 = K*TRANSIT1 -K*TRANSIT2;
					dxdt_TRANSIT3 = K*TRANSIT2 -K*TRANSIT3;
					dxdt_INPUT = -KIN*INPUT;
					dxdt_G4N1 = 0;
					if (ANC < 0.5) dxdt_G4N1 = 1;

$TABLE		table(IPRE) = CENT/V1;
'
# Compile the model code
mod <- mcode("popMELPH",code)
# There is opportunity to simply update model parameters after the model code has been compiled
